Braxia Scientific (TSE:BRAX) has released an update.
Braxia Scientific, a medical research and telemedicine company, has applied for a Management Cease Trade Order due to a delay in filing its annual financial statements, attributed to changes in senior management. While the general public can still trade the company’s securities, the MCTO will prevent company executives from doing so until the required financial documents are filed, which is expected by September 15, 2024.
For further insights into TSE:BRAX stock, check out TipRanks’ Stock Analysis page.
